Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen

To ameliorate multidrug resistance (MDR) observed in leukemia cells, nanomicelles modified by transferrin (Tf-M-DOX/PSO), coencapsulating doxorubicin (DOX) and psoralen (PSO), were designed, synthesized and tested in K562 and doxorubicin-resistant K562 (K562/DOX) cells. In vitro drug release kinetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, He-Wen, Ma, Ke-Ling, Liu, Hua, Zhou, Jia-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185111/
https://www.ncbi.nlm.nih.gov/pubmed/32259795
http://dx.doi.org/10.18632/aging.102992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185111/
https://www.ncbi.nlm.nih.gov/pubmed/32259795
http://dx.doi.org/10.18632/aging.102992

Ejemplares similares